ADCON-L

02/01/2003 - "Two-year results after lumbar microdiscectomy with and without prophylaxis of a peridural fibrosis using Adcon-L."
01/01/2001 - "Histopathological evaluation of the muscle revealed decreased fibrosis of perimuscular connective tissue in eyes treated with ADCON-L at 3 weeks postoperatively. "
09/01/2000 - "The authors review new opinions on pathophysiology of peridural fibrosis, clinical aspects of the process, results of experimental approaches for limiting peridural fibrosis and perspective of anti-adhesion gel Adcon-L."
01/01/1999 - "Prevention of epidural fibrosis with ADCON-L in presence of a durotomy during lumbar disc surgery: experiences with a pre-clinical model."
01/01/1999 - "ADCON-L was developed to decrease the peridural fibrosis reaction. "

01/01/1999 - "In addition, ADCON-L patients returned to their original jobs an average of 3.6 days sooner, changed jobs 50% less often, did not seek additional medical treatment as often, and took 20% less pain medication than did control patients (p = 0.01). "
01/01/1999 - "Repeated measures analysis demonstrated that patients who received treatment with ADCON-L at the time of surgery experienced less activity-related pain through the 12-month assessment (p = 0.05). "
01/01/1996 - "ADCON-L reduced the incidence of activity-related pain. "
02/01/1998 - "The incidence of activity-related pain was significantly reduced (P = 0.013), straight-leg-raise examination scores were significantly improved (P = 0.024 on the operative side and P = 0.015 on the nonoperative side), and ADCON-L reduced low back pain when it was most severe (P = 0.047) and at the end of the day (P = 0.044)."
09/01/2006 - "To determine whether ADCON-L Gel (ALG) or Preclude Spinal Membrane (PSM) was more effective in preventing scarring, reducing pain, and improving quality of life postoperatively. "

12/01/2008 - "Patients treated with ADCON-L did not demonstrate any adverse effects, nor did they demonstrate less scarring or better clinical outcome than control patients. "
03/01/2004 - "An absorbable ADCON-L gel has been shown to inhibit scar and epidural adhesions following spinal surgeries. "
10/01/2001 - "Use of ADCON-L gel, already commercially available, has been proven to reduce postoperative scarring in animal experiments. "
11/01/2000 - "Perspectives on modern orthopaedics: use of Adcon-L for epidural scar prevention."
01/01/1999 - "In addition, those patients receiving ADCON-L at surgery developed significantly less scar in the months following operation (p = 0.01, 6 and 12 months post-operatively). "

02/01/1998 - "The incidence of activity-related pain was significantly reduced (P = 0.013), straight-leg-raise examination scores were significantly improved (P = 0.024 on the operative side and P = 0.015 on the nonoperative side), and ADCON-L reduced low back pain when it was most severe (P = 0.047) and at the end of the day (P = 0.044)."
01/01/1999 - "Those patients treated with ADCON-L at surgery had significantly less scar than did control patients (p = 0.007), and had less low back pain than did control patients when the pain was most severe (p = 0.047) and when the pain was assessed at the end of the day (p = 0.044). "

03/01/2002 - "Efficacy of the morphine-Adcon-L compound in the management of postoperative pain after lumbar microdiscectomy."